Absence of functional peroxisome proliferator-activated receptor-α enhanced ileum permeability during experimental colitis

Shock

Volumn 28, Issue 2, 2007, Pages 192-201

  Mazzon, Emanuela ^b   Cuzzocrea, Salvatore ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE

Author keywords

Dinitrobenzene sulfuric acid; Inflammation; Intestinal permeability; PPAR ; TJ protein

Indexed keywords

CLAUDIN 2; DINITROBENZENE SULFURIC ACID; DNA NUCLEOTIDYLEXOTRANSFERASE; FAS LIGAND; LIGAND; OCCLUDIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN ZO1; SULFURIC ACID; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA PERMEABILITY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; RECEPTOR GENE; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

ANIMALS; CELL MEMBRANE PERMEABILITY; COLITIS, ULCERATIVE; ILEUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; PPAR ALPHA;

EID: 34547698923     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318033eb29     Document Type: Article

References (38)

1. Wallace JL, Ma L: Inflammatory mediators in gastrointestinal defense and injury. Exp Biol Med (Maywood) 226:1003-1015, 2001.
2. Clayburgh DR, Shen L, Turner JR: A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 84:282-291, 2004.
3. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H: Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341:1437-1439, 1993.
4. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC: Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94:2956-2960, 1999.
5. Arnott ID, Kingstone K, Ghosh S: Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 35:1163-1169, 2000.
6. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141:1539-1550, 1998.
7. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-1788, 1993.
8. Cordenonsi M, D'Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S: Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol 147:1569-1582, 1999.
9. Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR: ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141:199-208, 1998.
10. Citi S, Sabanay H, Jakes R, Geiger B, Kendrick-Jones J: Cingulin, a new peripheral component of tight junctions. Nature 333:272-275, 1988.
11. Jesaitis LA, Goodenough DA: Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J Cell Biol 124:949-961, 1994.
12. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA: Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103:755-766, 1986.
13. Van Itallie C, Rahner C, Anderson JM: Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107:1319-1327, 2001.
14. Colegio OR, Van Itallie C, Rahner C, Anderson JM: Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 284:C1346-C1354, 2003.
15. Van Itallie CM, Fanning AS, Anderson JM: Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 285:F1078-F1084, 2003.
16. Fais S, Capobianchi MR, Silvestri M, Mercuri F, Pallone F, Dianzani F: Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells. J Interferon Res 14:235-238, 1994.
17. Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, Turner JR: A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123:163-172, 2002.
18. Mullin JM, Laughlin KV, Marano CW, Russo LM, Soler AP: Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. Am J Physiol 263(pt 2):F915-F924, 1992.
19. Madara JL, Stafford J: Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724-727, 1989.
20. Taylor CT, Dzus AL, Colgan SP: Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. Gastroenterology 114:657-668, 1998.
21. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muia C, Centorrino T, Caputi AP: Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of inflammatory bowel disease in mice. Lab Invest 84:1643-1654, 2004.
22. Mansen A, Guardiola-Diaz H, Rafter J, Branting C: Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa. Biochem Biophys Res Commun 222:844-851, 1996.
23. Huin C, Corriveau L, Bianchi A, Keller JM, Collet P, Kremarik-Bouillaud P, Domenjoud L, Becuwe P, Schohn H, Menard D, et al.: Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract. J Histochem Cytochem 48:603-611, 2000.
24. Alnadjim Z, Kayali Z, Haddad W, Holmes EW, Keshavarzian A, Mittal N, Ivancic D, Koehler R, Goldsmith D, Waltenbaugh C, et al.: Barrett differential effects of T-cell activation on gastric and small bowel permeability in alcoholconsuming mice. Alcohol Clin Exp Res 26:1436-1443, 2002.
25. Mazzon E, Cuzzocrea S: Thalidomide treatment reduces the alteration of paracellular barrier function in mice ileum during experimental colitis. Shock 25:515-521, 2006.
26. Cuzzocrea S, Ayroldi E, Di Paola R, Agostini M, Mazzon E, Bruscoli S, Genovese T, Ronchetti S, Caputi AP, Riccardi C: Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB J 19:1253-1265, 2005.
27. Clark RB: The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400, 2002.
28. Peters JM, Hennuyer N, Staels B, Fruchart J-C, Fievet C, Gonzales FJ, Auwerx J: Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 272:27307-27312, 1997.
29. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273:5678-5684, 1998.
30. Devchand PR, Keller H, Peters JM, Vasquez M, Gonzales FJ, Wahli W: The PPAR-α-leukotriene B4 pathway to inflammation control. Nature 384:39-43, 1996.
31. Lilja I, Gustafson-Svard C, Franzen L, Sjodahl R: Tumor necrosis factor-alpha in ileal mast cells in patients with Crohn's disease. Digestion 61:68-76, 2000.
32. Schmitz H, Rokos K, Florian P, Gitter AH, Fromm M, Scholz P, Ullrich R, Zeitz M, Pauli G, Schulzke JD: Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS 16:983-991, 2002.
33. Sabelko-Downes KA, Russell JH: The role of Fas ligand in vivo as a cause and regulator of pathogenesis. Curr Opin Immunol 12:330-335, 2000.
34. Pinkoski MJ, Brunner T, Green DR, Lin T: Fas and Fas ligand in gut and liver. Am J Physiol Gastrointest Liver Physiol 278:G354-G366, 2000.
35. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Moller: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113:160-167, 1997.
36. Cuzzocrea S, Mazzon E, Di Paola R: Role of endogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-α) in the development of acute inflammation. J Leukoc Biol 79:999-1010, 2006.
37. Bojarski C, Gitter AH, Bendfeldt K: Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 535:541-552, 2001.
38. Gitter AH, Wullstein F, Fromm M, Schulzke JD: Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121:1320-1328, 2001.